The most common cause of bleeding disorders are platelet disorders which are often acquired instead of inherited.
Hereditary bleeding disorders occur as a result of the absence or deficiency of specific clotting proteins.
The 3 most common hereditary bleeding disorders are hemophilia A (factor VIII deficiency), hemophilia B (factor IX deficiency) and von Willebrand disease.
The rarest form of hemophilia is hemophilia C that is very rare and rarely causes serious medical issues.
Many people that have hemophilia C do not have any symptoms until they become adults and the symptoms they do get are usually very mild.
However even with hemophilia C you may develop bleeding problems after things such as surgery or dental treatments.
Hemophilia A is more severe and worse than hemophilia B.
Hemophilia A, is a hereditary hemorrhagic disorder resulting from a congenital deficit of factor VIII that manifests as protracted and excessive bleeding either spontaneously or secondary to trauma.
Hemophilia B is an inherited bleeding disorder and it happens when a gene that helps blood clot mutates or changes.
People with hemophilia B do not have the usual amount of a blood protein that helps blood clot.
This protein is a clotting factor.
Clotting factors are specialized proteins needed for blood clotting, the process by which blood seals a wound to stop bleeding and promote healing.
Hemophilia can result in bleeding within joints that can lead to chronic joint disease and pain.
Bleeding in the head and sometimes in the brain which can cause long term problems, such as seizures and paralysis.
Death can occur if the bleeding cannot be stopped or if it occurs in a vital organ such as the brain.
The life expectancy for people with hemophilia is now similar to that of the general population.
Most people with hemophilia are able to live full and normal lives with proper treatment.
People with severe hemophilia are at the highest risk of serious bleeding.
Hemophilia primarily affects males, but a symptomatic form of hemophilia B in female carriers has also been described with a generally milder clinical picture.